Literature DB >> 11807793

Influence of the mucosal epithelium microenvironment on Langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix.

Sandra L Giannini1, Pascale Hubert, Jean Doyen, Jacques Boniver, Philippe Delvenne.   

Abstract

We have addressed the notion that the initiation and progression of human papillomavirus associated cancer of the uterine cervix are associated with alterations of Langerhans cells (LC) within the mucosal squamous epithelium. Since the transformation zone (TZ) of the cervix is the site where the majority of squamous intraepithelial lesions (SIL) are initiated, in contrast to the exocervix, we decided to investigate the influence of the local microenvironment within the TZ on the function and density of LC. We show that the TZ is associated with a significant reduction in the density of immature LC (CD1a/LAG) compared to the exocervix. In contrast, the development of SILs is attributed with a relative increased density of immature LC, compared to the TZ. Furthermore, we show that this variability in LC density is correlated with a differential expression of TNFalpha and MIP3alpha within the micro-environment of the TZ and SILs. Both TZ and SIL epithelium-derived LC, in the presence of allogeneic PBMC, induced lower levels of proliferation and IL2 production and higher levels of the immunosuppressive cytokine IL10 in comparison to the exocervix. Nevertheless, the epithelium-derived LC in SILs exhibits a reduction in their functional activity, relative to the TZ. Together our studies suggest that the immunosurveillance within the epithelium of the TZ may be intrinsically perturbed due to the altered expression of chemokines/cytokines and the concomitant diminished density of LC. Furthermore, following HPV infection and the development of SILs, the function of LC may be further incapacitated by viral associated mechanisms. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807793     DOI: 10.1002/ijc.10084

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Alterations of T-cell surface markers in older women with persistent human papillomavirus infection.

Authors:  Ana Cecilia Rodríguez; Alfonso J García-Piñeres; Allan Hildesheim; Rolando Herrero; Matthew Trivett; Marcus Williams; Ivannia Atmella; Margarita Ramírez; Maricela Villegas; Mark Schiffman; Robert Burk; Enrique Freer; José Bonilla; Concepción Bratti; Ligia A Pinto
Journal:  Int J Cancer       Date:  2011-02-01       Impact factor: 7.396

2.  High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract.

Authors:  Rafael Jimenez-Flores; Rene Mendez-Cruz; Jorge Ojeda-Ortiz; Rebeca Muñoz-Molina; Oscar Balderas-Carrillo; Maria de la Luz Diaz-Soberanes; Serge Lebecque; Sem Saeland; Adrian Daneri-Navarro; Alejandro Garcia-Carranca; Stephen E Ullrich; Leopoldo Flores-Romo
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

3.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

4.  Transforming growth factor-beta1-mediated Slug and Snail transcription factor up-regulation reduces the density of Langerhans cells in epithelial metaplasia by affecting E-cadherin expression.

Authors:  Michael Herfs; Pascale Hubert; Natalia Kholod; Jean Hubert Caberg; Christine Gilles; Geert Berx; Pierre Savagner; Jacques Boniver; Philippe Delvenne
Journal:  Am J Pathol       Date:  2008-04-01       Impact factor: 4.307

5.  Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein.

Authors:  Joanna Laurson; Sadaf Khan; Rachel Chung; Karen Cross; Kenneth Raj
Journal:  Carcinogenesis       Date:  2010-02-01       Impact factor: 4.944

6.  Exodus-1 (CCL20): evidence for the participation of this chemokine in spontaneous labor at term, preterm labor, and intrauterine infection.

Authors:  Neil Hamill; Roberto Romero; Francesca Gotsch; Juan Pedro Kusanovic; Sam Edwin; Offer Erez; Nandor Gabor Than; Pooja Mittal; Jimmy Espinoza; Lara A Friel; Edi Vaisbuch; Shali Mazaki-Tovi; Sonia S Hassan
Journal:  J Perinat Med       Date:  2008       Impact factor: 1.901

7.  Intravaginal immunization of mice with recombinant Salmonella enterica serovar Typhimurium expressing human papillomavirus type 16 antigens as a potential route of vaccination against cervical cancer.

Authors:  Hakim Echchannaoui; Matteo Bianchi; David Baud; Martine Bobst; Jean-Christophe Stehle; Denise Nardelli-Haefliger
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

8.  Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized Poly-I:C.

Authors:  Diane M Da Silva; Andrew W Woodham; Joseph G Skeate; Laurie K Rijkee; Julia R Taylor; Heike E Brand; Laila I Muderspach; Lynda D Roman; Annie A Yessaian; Huyen Q Pham; Koji Matsuo; Yvonne G Lin; Greg M McKee; Andres M Salazar; W Martin Kast
Journal:  Clin Immunol       Date:  2015-09-08       Impact factor: 3.969

9.  Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions.

Authors:  Thiago Theodoro Martins Prata; Camila Mareti Bonin; Alda Maria Teixeira Ferreira; Cacilda Tezelli Junqueira Padovani; Carlos Eurico dos Santos Fernandes; Ana Paula Machado; Inês Aparecida Tozetti
Journal:  Immunology       Date:  2015-07-01       Impact factor: 7.397

10.  The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity.

Authors:  Maria Alice G Gonçalves; Edson G Soares; Eduardo A Donadi
Journal:  Infect Agent Cancer       Date:  2009-08-18       Impact factor: 2.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.